None
Quote | Correvio Pharma Corp. (NASDAQ:CORV)
Last: | $0.4199 |
---|---|
Change Percent: | 0.82% |
Open: | $0.416 |
Close: | $0.4199 |
High: | $0.42 |
Low: | $0.416 |
Volume: | 3,745,968 |
Last Trade Date Time: | 05/26/2020 04:46:23 am |
News | Correvio Pharma Corp. (NASDAQ:CORV)
NASDAQ: CORV TSX: CORV VANCOUVER , May 21, 2020 /PRNewswire/ - Correvio Pharma Corp. (" Correvio " or the " Company ") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained a final order...
Merger activity sputtered to a stop again last week with no new deals announced and one deal closing. This is the fifth week this year with no new deals announced. There were however some potential deals that were announced last week. On Monday, May 11, 2020, according to Bloomberg, Amazon.c...
Message Board Posts | Correvio Pharma Corp. (NASDAQ:CORV)
Subject | By | Source | When |
---|---|---|---|
$corv $0.4199 ? 0.0 (0.00%) | Taurus69 | investorshub | 03/14/2021 8:39:08 PM |
$corv $0.4199 ? 0.0 (0.00%) | Taurus69 | investorshub | 02/14/2021 12:16:29 AM |
$corv $0.4199 ? 0.0 (0.00%) | Taurus69 | investorshub | 01/26/2021 7:47:35 PM |
$corv $0.4199 ? 0.0 (0.00%) | Taurus69 | investorshub | 01/03/2021 9:06:21 PM |
$corv $0.4199 ? 0.0 (0.00%) | Taurus69 | investorshub | 12/08/2020 11:26:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Correvio Pharma Corp. Company Name:
CORV Stock Symbol:
NASDAQ Market:
NASDAQ: CORV TSX: CORV VANCOUVER , May 21, 2020 /PRNewswire/ - Correvio Pharma Corp. (" Correvio " or the " Company ") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained a final order...
Correvio Announces Results from Annual General and Special Meeting of Securityholders Canada NewsWire VANCOUVER, May 15, 2020 Securityholders Approve ADVANZ PHARMA Acquisition NASDAQ: CORV TSX: CORV VANCOUVER , May 15, 2020 /CNW/ - Correvio Pharma Cor...
NASDAQ: CORV TSX: CORV VANCOUVER , May 6, 2020 /PRNewswire/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading independent proxy advisory firm, released a report...